A Functional Interaction Between Hippo-YAP Signalling and SREBPs Mediates Hepatic Steatosis in Diabetic Mice
Overview
Molecular Biology
Affiliations
The Hippo pathway is an evolutionarily conserved regulator of organ size and tumorigenesis that negatively regulates cell growth and survival. Whether the Hippo pathway regulates cell metabolism is unknown. Here, we report that in the nucleus of hepatocytes, Yes-associated protein(YAP)-the terminal effector of the Hippo pathway-directly interacts with sterol regulatory element binding proteins (SREBP-1c and SREBP-2) on the promoters of the fatty acid synthase (FAS) and 30-hydroxylmethyl glutaryl coenzyme A reductase (HMGCR), thereby stimulating their transcription and promoting hepatocyte lipogenesis and cholesterol synthesis. In diet-induced diabetic mice, either Lats1 overexpression or YAP knockdown protects against hepatic steatosis and hyperlipidaemia through suppression of the interaction between YAP and SREBP-1c/SREBP-2. These results suggest that YAP is a nuclear co-factor of SREBPs and that the Hippo pathway negatively affects hepatocyte lipogenesis by inhibiting the function of YAP-SREBP complexes.
Li L, Niu X, Zhang W, Wang Z, Zhang S, Zhang Q Am J Transl Res. 2024; 16(11):7186-7199.
PMID: 39678602 PMC: 11645594. DOI: 10.62347/VXHU6738.
Hepatocyte-Specific Knockout Maintained the Liver Homeostasis of Lipid Metabolism in Mice.
Li C, Xue Y, Liu Y, Zheng K, Gao Y, Gong Y Diabetes Metab Syndr Obes. 2024; 17:3197-3214.
PMID: 39220798 PMC: 11365535. DOI: 10.2147/DMSO.S472778.
Clark K, George J, Davis J Toxicol Sci. 2024; 202(1):36-49.
PMID: 39141488 PMC: 11514835. DOI: 10.1093/toxsci/kfae103.
Benhammou J, Sinnett-Smith J, Pisegna J, Rozengurt E Gastro Hep Adv. 2024; 2(2):232-241.
PMID: 39132609 PMC: 11308718. DOI: 10.1016/j.gastha.2022.07.017.
Lipid metabolism dynamics in cancer stem cells: potential targets for cancers.
Du J, Qin H Front Pharmacol. 2024; 15:1367981.
PMID: 38994204 PMC: 11236562. DOI: 10.3389/fphar.2024.1367981.